High-Intensity Focused Ultrasound Enhanced Anti-Tumor Activities of Paclitaxel in Breast Cancer in vitro and in vivo

BACKGROUND: Paclitaxel (PTX) is an important oncologic chemotherapeutic agent against breast cancer, but breast cancer patients develop significant resistance to PTX during chemotherapy. Alterations in tubulin and associated proteins have been implicated in resistance to PTX. High-intensity focused...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sha, Bian, Hao, Duan, Jingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978695/
https://www.ncbi.nlm.nih.gov/pubmed/35386184
http://dx.doi.org/10.2147/CMAR.S349409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978695/
https://www.ncbi.nlm.nih.gov/pubmed/35386184
http://dx.doi.org/10.2147/CMAR.S349409

Ejemplares similares